Outlook Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.76

-0.13 (-14.90%)

As of Aug 15, 2:28 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 78%

Hold 2 22%

Sell 0 0%

Price Target

Analyst Price Target +4,498.1% upside

Low Target $27.07

Average Target $34.78

High Target $51.13

Current Price $0.76

Current
$0.76

Target
$34.78

$27.07 $34.78 avg $51.13

Scenario Analysis

Bear Case

$27.07

3,478.8%

Low target

Base Case

$34.78

+4,498.1%

Avg target

Bull Case

$51.13

+6,659.7%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$3.39

-77.7% from high

52-Week Low

$0.16

+369.5% from low

Target vs 52W High

$34.78

+926.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%